Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, August 03, 2017
Moderna announced Juan Andres has joined the company as Senior Vice President of Late Stage Technical Development and Manufacturing (beyond human proof of concept).
read more
Monday, November 16, 2020
Moderna announced the DSMB for the Phase 3 study of mRNA-1273 has informed the company the trial has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%.
read more
Moderna has announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against COVID-19 has begun dosing participants.
read more
Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that it has entered into an additional agreement with Lonza to support drug substance manufacturing for its global supply chain. The agreement will ...
read more
Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics, a leading global CDMO providing a fully integrated end-to-end contract development and manufacturing service, announced a Manufacturing...
read more
Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Medison Pharma, a leading commercial partner for highly innovative therapies in international markets, announced a new agreement to commercialize the ...
read more
Moderna, Inc. and Catalent, Inc. today announced the expansion of their strategic collaboration to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine and potentially other investigational programs in ...
read more
Tuesday, October 08, 2013
Modality Solutions, a privately-held company that delivers integrated cold chain management solutions for highly regulated industries, released its white paper “The Cold Hard Facts: What You Need to Know About Thermal Shipping Technologies” at the ...
read more
Modality Solutions, LLC, a privately-held company that delivers integrated cold chain management solutions for highly regulated industries, has named Shubhra Kochar Consulting Engineer.
read more
Wednesday, August 27, 2014
As approved business partners, Modality Solutions and DeltaTrak will offer their life science customers implementation and validation services in conjunction with cold chain monitoring device technology in order to ensure regulatory compliance.
read more
Modality Solutions and CSafe announced a strategic partnership to provide a next-generation cold chain solution for cell and gene therapies (CGTs).
read more
Mobidiag has signed an agreement with Ginolis, knowledgeable in assembly automation and high precision liquid handling solutions.
read more
Tuesday, November 03, 2015
Moberg Pharma AB has announced that Moberg Pharma and Colep have entered a Development Agreement for MOB-015 – a novel topical formulation of terbinafine for onychomycosis (nail fungus).
read more
Thursday, October 11, 2018
MMS announced their support to Paratek for the NDA approval and successful MAA filing of Nuzyra for the treatment of adults with CABP and ABSSSI.
read more
MMS Holdings has joined an alliance of fifty life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.
read more